Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Non-Current Liabilities (2016 - 2025)

Wave Life Sciences' Total Non-Current Liabilities history spans 11 years, with the latest figure at $17.2 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 27.92% year-over-year to $17.2 million; the TTM value through Dec 2025 reached $17.2 million, down 27.92%, while the annual FY2025 figure was $17.2 million, 27.92% down from the prior year.
  • Total Non-Current Liabilities reached $17.2 million in Q4 2025 per WVE's latest filing, down from $23.1 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $161.5 million in Q1 2023 to a low of $17.2 million in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $80.6 million, with a median of $101.7 million recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: soared 59.86% in 2023, then plummeted 77.63% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $102.4 million in 2021, then increased by 9.42% to $112.1 million in 2022, then plummeted by 63.42% to $41.0 million in 2023, then crashed by 41.8% to $23.9 million in 2024, then fell by 27.92% to $17.2 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Total Non-Current Liabilities are $17.2 million (Q4 2025), $23.1 million (Q3 2025), and $17.8 million (Q2 2025).